ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AHR American Healthcare REIT Inc

14.42
0.00 (0.00%)
Pre Market
Last Updated: 09:09:56
Delayed by 15 minutes
Share Name Share Symbol Market Type
American Healthcare REIT Inc NYSE:AHR NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.42 0 09:09:56

- Current report filing (8-K)

12/11/2009 9:25pm

Edgar (US Regulatory)


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
     November 12, 2009 (November 9, 2009)

Anthracite Capital, Inc.
(Exact name of registrant as specified in its charter)


Maryland
001-13937
13-3978906
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)


40 East 52nd Street, New York, New York  
 
10022
(Address of principal executive offices)
 
(Zip Code)


Registrant’s telephone number, including area code
     (212) 810-3333


N/A
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)

On November 9, 2009, the Board of Directors (the “Board”) of Anthracite Capital, Inc. (the “Company”) elected Kathleen M. Hagerty to the Board. Ms. Hagerty has not been named to any committee of the Board at this time. Ms. Hagerty has no material interest in any transaction or proposed transaction to which the Company was or is to be a party.
 
A copy of the press release of the Company announcing Ms. Hagerty’s election to the Board is filed as Exhibit 99.1 hereto and incorporated herein by reference.
 
Item 9.01.
Financial Statements and Exhibits.

(d)        Exhibits.
 

Exhibit No.
Document
99.1
Press release dated November 10, 2009
 


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
ANTHRACITE CAPITAL, INC.
       
       
 
By:
/s/ Richard M. Shea
 
 
Name:
Richard M. Shea
 
 
Title:
President and Chief Operating Officer
 
       
 
Dated:
November 12, 2009
 




1 Year American Healthcare REIT Chart

1 Year American Healthcare REIT Chart

1 Month American Healthcare REIT Chart

1 Month American Healthcare REIT Chart